Life Science Tools Market Report 2026

Life Science Tools Market Overview

• Life Science Tools market size has reached to $201.37 billion in 2025 • Expected to grow to $379.95 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rise In Demand for Biopharmaceuticals Driving The Market Growth Due To Expansion Of Biologic Drug Development And Manufacturing • Market Trend: Impact Of Advanced Sequencing Platforms On Research And Clinical Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Life Science Tools Market?

Life science tools are specialized resources and systems that support the study, examination, and understanding of living organisms and their biological functions. They play a crucial role in enabling researchers to collect precise and reliable data, which is essential for analyzing and interpreting various aspects of life processes. By providing the means to investigate complex biological mechanisms, these tools form an integral part of scientific exploration and the advancement of knowledge in the life sciences. The main types of life science tools are instruments, consumables, and services. Instruments are essential laboratory devices used for analyzing biological samples and conducting precise scientific experiments. Various technologies are used, such as polymerase chain reaction (PCR) and quantitative PCR (qPCR), sanger sequencing, separation technologies, flow cytometry, nucleic acid microarray, mass spectrometry, and others. These tools are applied in drug discovery and development, clinical diagnostics, genomic and proteomic research, cell biology research, and other areas by several end users, including academic and research institutions, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations (CROs), and government and regulatory agencies.

What Is The Life Science Tools Market Growth Forecast?

The life science tools market size is expected to see rapid growth in the next few years. It will grow to $379.95 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to integration of automation and smart laboratory equipment, increasing investment in genomics and proteomics research, rising demand for personalized medicine, expansion of clinical diagnostics and drug discovery applications, adoption of cloud-based data analytics and digital lab solutions. Major trends in the forecast period include increasing adoption of high-throughput instruments and automation, rising demand for advanced consumables and reagents, expansion of genomic, proteomic, and cell biology research, growing focus on contract research organizations (cros), enhanced quality control and calibration services for life science tools.

Global Life Science Tools Market Segmentation

1) By Type: Instruments, Consumables, Services 2) By Technology: Polymerase Chain Reaction(PCR) And Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, Other Technologies 3) By Application: Drug Discovery And Development, Clinical Diagnostics, Genomic And Proteomic Research, Cell Biology Research, Other Applications 4) By End-User: Academic And Research Institutions, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations (CROs), Government And Regulatory Agencies Subsegments: 1) By Instruments: Microscopes, Sequencers, Analyzers, Spectrometers, Centrifuges, Chromatography Systems, Laboratory Automation Equipment 2) By Consumables: Reagents, Kits, Culture Media, Pipettes And Tips, Plasticware, Laboratory Chemicals, Assay Kits 3) By Services: Calibration Services, Maintenance And Repair, Laboratory Testing Services, Consulting Services, Training And Support, Research And Development Services

What Is The Driver Of The Life Science Tools Market?

The rise in demand for biopharmaceuticals is expected to propel the growth of the life science tools market going forward. Biopharmaceuticals refer to medical drugs produced using biotechnology, which involves biological sources such as living cells or organisms to create therapies including proteins, antibodies, or vaccines. The rise in demand for biopharmaceuticals is primarily due to their ability to effectively treat complex and chronic diseases that traditional small-molecule drugs cannot adequately address. Life science tools enable the development and manufacturing of biopharmaceuticals by providing essential technologies for research, analysis, and quality control throughout the drug production process, ensuring accuracy, efficiency, and compliance with regulatory standards. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the US had 33 biosimilar products approved by the FDA, with 21 of them available on the market. By 2023, the number of FDA-approved biosimilars had risen to 40, with 25 commercially available. Therefore, the rise in demand for biopharmaceuticals is driving the growth of the life science tools industry.

Key Players In The Global Life Science Tools Market

Major companies operating in the life science tools market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Lonza Group Ltd., Illumina Inc., Sartorius AG, Shimadzu Corporation, Revvity Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Eppendorf AG, Tecan Group Ltd., Bio-Techne Corporation, Takara Bio Inc., GenScript Biotech Corporation, 10x Genomics Inc., Hamilton Company.

Global Life Science Tools Market Trends and Insights

Major companies operating in the life science tools market are focusing on developing innovative solutions, such as automated sequencing platforms, to enhance efficiency, accuracy, and accessibility in genetic analysis, thereby accelerating research and clinical diagnostics. Automated sequencing platforms are advanced systems that perform DNA or RNA sequencing with minimal manual intervention using robotics and software, helping to increase throughput, reduce errors, and enable faster, more reliable genetic research and diagnostics. For instance, in October 2024, Illumina Inc., a US-based biotechnology company, launched the MiSeq i100 series, its simplest and fastest benchtop sequencers designed to make next-generation sequencing more accessible to a wider range of laboratories. The new MiSeq i100 and MiSeq i100 Plus Systems offer room-temperature kit storage and shipping, eliminating delays caused by reagent thawing and enabling same-day sample-to-analysis workflows. These platforms provide rapid sequencing with run times as short as four hours, cost-effective consumables, and user-friendly, push-button workflows that support various applications in microbiology, infectious disease, and oncology. This innovation exemplifies the market’s shift toward efficient, scalable, and easy-to-use sequencing tools that empower researchers and clinicians alike.

What Are Latest Mergers And Acquisitions In The Life Science Tools Market?

In July 2025, Bio-Rad Laboratories Inc., a US-based life sciences and clinical diagnostics technology company, acquired Stilla Technologies for an undisclosed amount. With this acquisition, Bio-Rad aims to strengthen its position in the biotechnology sector by integrating Stilla’s next-generation digital PCR systems, consumables, and assays into its portfolio, thereby enhancing its capabilities in oncology diagnostics, cell and gene therapy, and infectious disease testing across both research and clinical applications. Stilla Technologies SA is a France-based biotechnology company specializing in digital PCR instruments and molecular diagnostic solutions.

Regional Outlook

North America was the largest region in the life science tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Life Science Tools Market?

The life science tools market consists of revenues earned by entities by providing services such as laboratory testing and analysis, bioprocessing equipment supply, clinical trial support services, and quality control. The market value includes the value of related goods sold by the service provider or included within the service offering. The life science tools market also includes sales of western blotting, bioreactors, centrifuges, and microfluidics and lab-on-a-chip devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.